Viatris Inc.
NASDAQ:VTRSDrug Manufacturers - Specialty & Generic
-$0.36 today
- Market cap
- $23.25B
- Beta
- 0.90
- P/E (TTM)
- -59.9
- EPS (TTM)
- -$0.26
- Dividend yield
- 3.12%
Volume 13.21M
Average 10.58M
VTRS Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Viatris Inc.NASDAQ: VTRS
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue grows, but more slowly than its trailing trend
Q2 FY2026 cost of revenue of $2.3B rose 2.3% year over year, behind the +7.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 2.5% from the prior quarter. Over 3 fiscal years it compounded at -1.7% a year.
Context
- Cost of revenue amounted to 64.9% of revenue in FY2025, up 3.1 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +2.3% toward the trailing-twelve-month pace of +7.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 9.29B USD
- Year-over-year change
- +1.9%
- 4-year CAGR
- -6.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.29B | +1.9% |
| FY2024 | 2024-12-31 | 9.12B | +1.4% |
| FY2023 | 2023-12-31 | 8.99B | -8.0% |
| FY2022 | 2022-12-31 | 9.77B | -20.7% |
| FY2021 | 2021-12-31 | 12.31B | — |
Cost of Revenue vs competitors
How VTRS compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +7.3% is the 4th highest of 9, against a peer median of +6.1%.
- Cost of revenue amounts to 65.2% of revenue for VTRS, versus a peer median of 46.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | ₹167.45B INR | +12.3% | +16.2% | 50.5% | |
| LTM Jun 2026 | $9.6B USD | +7.3% | -1.7% | 65.2% | |
| LTM Jun 2026 | $8.23B USD | -1.8% | +1.5% | 47.5% | |
| LTM Jun 2025 | £6.09B GBP | — | -3.6% | 36.8% | |
| LTM Jun 2026 | $3.06B USD | +5.9% | +8.4% | 28.2% | |
| LTM Sep 2026 | $2.84B USD | +0.3% | +7.6% | 46.6% | |
| LTM Jun 2026 | $1.89B USD | +6.4% | +9.8% | 60.7% | |
| LTM Mar 2026 | $379.4M USD | +5.6% | +13.3% | 52.7% | |
| LTM Mar 2026 | $314.64M USD | +14.8% | +46.1% | 34.1% | |
| LTM Sep 2026 | $300.12M USD | +41.3% | -3.4% | 17.1% | |
| Peer median (excluding VTRS) | — | +6.1% | +8.4% | 46.6% | |
Competitors are the stored peer set for VTRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.89B | 16.26B | 15.43B | 14.74B | 14.3B |
| Cost of Revenue | 12.31B | 9.77B | 8.99B | 9.12B | 9.29B |
| Gross Profit | 5.58B | 6.5B | 6.44B | 5.62B | 5.01B |
| Gross Margin | 31.2% | 40.0% | 41.7% | 38.2% | 35.1% |
| Research & Development | 681M | 662.2M | 805.2M | 808.7M | 965.9M |
| Selling, General & Admin | 4.53B | 4.18B | 4.65B | 4.43B | 3.79B |
| Operating Expenses | 5.61B | 4.88B | 5.67B | 5.61B | 7.68B |
| Depreciation & Amortization | 4.51B | 3.03B | 2.74B | 2.71B | 2.8B |
| EBITDA | 4.48B | 6.43B | 3.52B | 2.64B | (395.4M) |
| EBITDA Margin | 25.0% | 39.6% | 22.8% | 17.9% | -2.8% |
| Operating Income | (34M) | 1.61B | 766.2M | 10.1M | (2.66B) |
| Operating Margin | -0.2% | 9.9% | 5.0% | 0.1% | -18.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 636.2M | 592.4M | 573.1M | 550M | 471.3M |
| Other Income / Expenses | (630.4M) | 1.2B | (563.3M) | (633.3M) | (1B) |
| Income Before Tax | (664.4M) | 2.81B | 202.9M | (623.2M) | (3.67B) |
| Pre-Tax Margin | -3.7% | 17.3% | 1.3% | -4.2% | -25.6% |
| Income Tax Expense | 604.7M | 734.6M | 148.2M | 11M | (150.1M) |
| Net Income | (1.27B) | 2.08B | 54.7M | (634.2M) | (3.51B) |
| Net Margin | -7.1% | 12.8% | 0.4% | -4.3% | -24.6% |
| EPS (Basic) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| EPS (Diluted) | (1.05) | 1.71 | 0.05 | (0.53) | (3.00) |
| Weighted Avg Shares | 1.21B | 1.21B | 1.2B | 1.19B | 1.17B |
| Weighted Avg Shares (Diluted) | 1.21B | 1.22B | 1.21B | 1.19B | 1.17B |
Viatris Inc.
NASDAQ:VTRS
Intrinsic Alpha fair value
Locked
Current Price
$20.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.